Plants, fungi and bacteria produce a variety of bioactives that alter cell metabolism, sometimes to the point of cell death.

NEW YORK, NY / ACCESSWIRE / November 24, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want ...

An ageing global population increases the prevalence of CKD, leading to market expansion and a growing need for treatment ...

and what actions you might take to counter these challenges: 1. Pace of change in your market exceeds your product cycle. In ...

Subset analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis in difficult-to-treat MASH patientsBoth artificial ...

A class action lawsuit has already been filed ... a once-daily oral Janus kinase ("JAK") inhibitor for canine dermatology, was less safe than Elanco had led investors to believe; (2) Elanco was ...

Other companies with KRAS inhibitors in the pipeline include Eli ... Unlock real-time insights & actions from data. Click here for more. In the age of AI, large data sets – like the treasure ...

Tubular glucose reabsorption is performed by the combined action of Na + /D-glucose SGLTs co-transporters and GLUT-facilitated diffusion glucose transporters. SGLT2 inhibitors are a new family of ...

Interleukin-23 inhibitor risankizumab for plaque psoriasis ... Unlock real-time insights & actions from data. Click here for more.